FDA campaign H-0579-2025
Class IIHazard
Product tested elevated coliform counts during routine testing
Distribution
The recalled product was distributed to the following states: DE, NY, FL, MD, IN, NC, OH
REKALLD area-alert coverage: nationwide (our reading of the distribution above)
The text above is quoted verbatim from the FDA record. Confirm the affected units and the remedy with the manufacturer or FDA. Recall data may be incomplete, delayed, or superseded.